Status | Study |
ACTIVE_NOT_RECRUITING |
Study Name: Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT Condition: Retinitis Pigmentosa Date: 2023-04-06 Interventions: The goal of this observational study is to assess the reliability and validity of the multi-luminance Y-Mobility Test (MLYMT) and multi-luminance s |
NOT_YET_RECRUITING |
Study Name: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III Condition: Date: 2023-03-14 Interventions: 1.5 million cells of UC-MSC in 2 ml of Conditioned Medium (CM) |
RECRUITING |
Study Name: Promising ROd-cone DYstrophy Gene therapY Condition: Retinitis Pigmentosa Date: 2023-02-07 Interventions: AAV-RdCVF-RdCVFL |
RECRUITING |
Study Name: Oral N-acetylcysteine for Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2022-09-08 Interventions: After randomization, participants will be given about 10-months supply of study drug (intervention), with instructions to take 3 effervescent tablets |
RECRUITING |
Study Name: High Resolution Retina Imaging Condition: Retinitis Pigmentosa Date: 2019-10-14 |
Recruiting |
Study Name: Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing. Condition: Retinitis Pigmentosa Date: 2016-08-01 |
Recruiting |
Study Name: Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2016-06-22 Interventions: Drug: levodopa-carbidopa sinemet 200/50 1/2 tablet b.i.d. for 2 days and then t.i.d for 6 months |
Recruiting |
Study Name: Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial Condition: Retinitis Pigmentosa Date: 2016-04-25 |
Recruiting |
Study Name: RST-001 Phase I/II Trial for Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2015-09-21 Interventions: Drug: RST-001 RST-001 is a gene therapeutic delivered by intravitreal injection |
Not yet recruiting |
Study Name: Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study Condition: Retinitis Pigmentosa Date: 2015-09-09 Interventions: Device: Transcorneal Electrical Stimulation using Okustim device The Okustim® stimulation device is |